Scott & White Vascular Institute Earns Joint Commission Certification for VAD
a news release.
Destination therapy is permanent support for end-stage heart failure by means of an implantable artificial heart device.
Scott & White underwent an on-site survey by a team of Joint Commission surveyors who evaluated Scott & White's Heart & Vascular Institute's VAD program for compliance with standards of care specific to the needs of patients and families, including infection prevention and control, leadership and medication management. The approval means the program demonstrated compliance with The Joint Commission's national standards for healthcare quality and safety in disease-specific care.
Related Articles on The Joint Commission:
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New From Becker's ASC Review
3 key questions for ambulatory healthcare leadersRead Now
- GI physician leader to know: Dr. Marla Dubinsky of Mount Sinai Hospital
- CMOSIS plans to open U.S. office
- Fischer Laser Eye Center among first to adopt topography-assisted LASEK procedure
- British Journal of Anaesthesia names Dr. Kane Pryor to associate editorial board
- Pivotal moments in GI: 4 gastroenterologists share the turning points of their career